Intellectual Property India Publishes Patent Application for 'Antibody Drug Conjugates That Bind Cdcp1 And Uses Thereof' Filed by Pheon Therapeutics Ltd.

MUMBAI, India, April 18 -- Intellectual Property India has published a patent application (202517007971 A) filed by Pheon Therapeutics Ltd., Harpenden, U.K., on Jan. 30, for 'antibody drug conjugates that bind cdcp1 and uses thereof.'

Inventor(s) include Jackson, Paul Joseph Mark; Procopiou, George; Thurston, David Edwin; and Zawel, Leigh.

The application for the patent was published on April 18, under issue no. 16/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure provides antibody-drug conjugates (ADCs), linkers, and compounds thereof useful for treating cancer."

The patent application was internationally filed on July 15, 2023, under International application No.PCT/IB2023/057250.

Di...